It is of interest to note that psychotropic medications that treat bipolar disorder (lithium) and anxiety states (selective serotonin reuptake inhibitors, SSRIs) appear to attenuate the activity of PKC, as discussed below, suggesting by inference that these mental states may result from an overactivity of PKC itself
Long-Term Safety: What We Know and Don't Know What We Know (From TRIUMPH-4 and TRIUMPH-1) Up to 80 weeks of data: Side effects improve significantly after dose escalation (first 16 weeks hardest) No unexpected safety signals in either trial Dysesthesia doesn't worsen over time (stable) Discontinuation rates stabilize (most who stop do so in first 24 weeks) No deaths attributed to retatrutide in any completed trial TRIUMPH-1 104-week extension shows continued weight loss without new safety signals What We Don't Know Yet Longer-term questions (need 25+ years data): Does dysesthesia resolve completely if medication stopped
Godex DS is hygroscopic, therefore be cautious on storing after opening the case
Your healthcare providers may help by adjusting your medications, strategizing to manage your symptoms, or determining solutions to meet your energy and nutrient needs
Managing side effects without abandoning the protocol Nausea is the side effect that causes the most people to quit semaglutide, and in many cases, it is manageable with straightforward adjustments